Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07527481) titled 'Nortriptyline and the Risk of Serious Adverse Events' on April 7.

Study Type: Observational

Primary Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Condition: Chronic Kidney Disease

Intervention: Drug: Nortriptyline Hydrochloride

Recruitment Status: Not recruiting

Date of First Enrollment: January 1, 2008

Target Sample Size: 5000

To know more, visit https://clinicaltrials.gov/study/NCT07527481

Disclaimer: Curated by HT Syndication....